Bile Duct Cancer Treatment

Specialist assessment and treatment pathway for cholangiocarcinoma

Bile duct cancer (cholangiocarcinoma) is a rare but serious malignancy of the biliary tree. Early diagnosis opens the door to curative surgical resection; advanced disease is managed with chemotherapy, targeted therapy and palliative biliary drainage. Our clinic coordinates specialist assessment and treatment pathway referrals for patients with confirmed or suspected cholangiocarcinoma.

Assessment includes MRCP, CT staging, CA 19-9 testing and tissue biopsy via ERCP where indicated; surgical suitability is evaluated with a hepatobiliary surgery team as part of a multidisciplinary approach.

Key Benefits

Specialist hepatobiliary assessment and staging
ERCP and stenting for biliary obstruction relief
Referral to hepatobiliary surgery for resectable disease
Multidisciplinary oncology team coordination

Is This Treatment Right For You?

Patients with jaundice, weight loss and elevated CA 19-9
Those with imaging findings suggesting biliary tract pathology
Patients with confirmed cholangiocarcinoma needing treatment coordination

What to Expect

Specialist Consultation

Symptoms, imaging and investigation results reviewed.

Staging Investigations

CT, MRCP, CA 19-9 and biopsy via ERCP if indicated.

MDT Assessment

Multidisciplinary team reviews staging and discusses treatment options.

Treatment Coordination

Surgery, chemotherapy or palliative biliary drainage initiated.

Recovery & Aftercare

Depends on treatment; ERCP biliary stenting has 1–2 days recovery; surgical resection requires 4–6 weeks.

Frequently Asked Questions

Is bile duct cancer curable?

Resectable early-stage cholangiocarcinoma can be cured with surgery; advanced disease is managed to extend survival and maintain quality of life.

What causes bile duct cancer?

Risk factors include primary sclerosing cholangitis, chronic hepatitis B/C, bile duct cysts and liver fluke infection; many cases have no identifiable cause.